img_hblbg.jpg
logo.jpg
img_hbrbg.jpg

Milestones

  • January -
     
    Acquisition of 100% share capital of Pisgah Labs Inc., a North Carolina Corporation, Old Hendersonville Highway, Pisgah Forest, North Carolina, USA (Pisgah) - A chemistry solutions provider, by Ipca Pharmaceutical Inc., USA (Company's wholly owned subsidiary) and Onyx Scientific Ltd., UK (Onyx) (Company's wholly owned step down subsidiary) for US$ 9.65 million free of debt.
    March -
     
    Ipca Laboratories received the “Best 4 Star Export House Award” at ECGC Indian Exporters Excellence 2017. This event was organised by ECGC - DUN & BRADSTREET at ITC, New Delhi on 6th March ’18. This award was presented by Honorable Union Minister for Commerce & Industry, Shri. Suresh Prabhu along with Chairman and Managing Director of ECGC, Mrs. Geetha Muralidhar, IAS Officer & Commerce Secretary, Mrs. Rita Teodia and Executive Director of ECGC, Mr. M. Sentilnathan.
    April -
     
    Preliminary results of Ipca’s Phase 4 study on Hydroxychloroquine in diabetes published in ‘Endocrine Practice Clinical and Investigative Endocrinology and Diabetes” - April 2018 Volume 24, Supplement 1. Abstract #209.
    May -
     
    Ipca Laboratories has been accredited with AEO Certification (Authorised Economic Operator) by the Ministry of Finance under T1 category in compliance with World Custom Organization Standards to secure and facilitate global trade framework i.e. WCO’s SAFE framework. This is the high level of facilitation to an organisation by Government of India. This recognition is accepted worldwide as safe, secure and compliant business partners in International Trade.
     
    Ipca Laboratories - Ratlam won the “Silver Award” presented by SEEM National Energy Management Awards - 2017 (Society of Energy Engineers and Managers) on 25th May 2018 at Institution of Engineers, New Delhi.
    The award given by Dr. Ajay Mathur (Director General of TERI - The Energy & Resources Institute and Ex. Director General of BEE - Bureau of Energy Efficiency, Ministry of Power), Mr. Saurabh Kumar (Managing Director - Energy Efficiency Services Limited), Mr. U.V.K. Rao President - SEEM, Mr. Jayakumar Nair Chairman – SEEM and Mr. K.K. Chakarvati Energy Economist - Knowledge Exchange Partner.
     
    Novel Antioxidant Launched - Eyesurge
    Ipca’s domestic marketing division – Ipca Optima has introduced Eyesurge in May ‘18, India’s first novel antioxidant – Small Size Big Nutrition. Ipca Optima has taken this initiative to provide ideal, rational therapeutic formulation by introducing India’s first ocular eye nutrition.
     
    Preliminary results of Ipca’s Phase 4 study on Hydroxychloroquine was presented at American Association of Clinical Endocrinologists (AACE) 27th Annual Scientific & Clinical Congress in Boston, MA.
    The details of abstract presented at AACE was covered in ‘Practice Update’ (Practice Update is a free online resource exclusively for healthcare professionals, www.practiceupdate.com).
    June -
     
    Study on CTD Vs HCTZ by ABPM (Ambulatory Blood Pressure Monitoring) has been referred to in two chapters (46 and 47) on hypertension in the latest edition of prestigious Braunwald’s Heart Disease - A text book of cardiovascular medicine.
    October -
     
    Acquisition of 80% share capital of Bayshore Pharmaceuticals LLC, New Jersey, USA by Ipca Pharmaceutical Inc., USA (Company’s wholly owned subsidiary).
    Bayshore Pharmaceuticals LLC (Bayshore), New Jersey, USA was originally founded in the year 2011 as a sales and marketing company for FDA approved generics drug products in the United States of America. Bayshore is currently engaged in the selling and marketing of its own registered generics drug products as well as the registered generics drug products of other pharmaceutical companies. The acquisition in Bayshore will enable the Company to commercialise its registered Generics Drug Products in the US market, through this entity.
    November -
     
    Ipca was shortlisted as finalist in the category of Clinical Advance of the Year for its Phase-4 study on Hydroxychloroquine in diabetes at the 14th Annual Scrip Awards held at London, UK.
    December -
     
    Ipca’s manufacturing plant at Ratlam won the 1st Prize in NECA, National Energy Conservation Award - 2018 (Ministry of Power, Govt. Of India) on 14th December 2018 on the occasion of Energy Conservation Day at Vigyan Bhawan, New Delhi. The award given by Hon. Mrs. Sumitra Mahajan (Loksabha Speaker) and Hon. Mr. R. K. Singh (Minister of State [Independent Charge] for Power, Coal, New & Renewable Energy and Mines), Government of India, New Delhi.
    Prior to this, Ipca’s Ratlam plant won 1st prize in 2016, 3rd prize in 2010, 2nd prize in 2007 in NECA.

Copyright © Ipca Laboratories Ltd. 2012. All Rights Reserved.